针对p185HER2过表达肿瘤的免疫疗法。 - Suppr

Towards an immunotherapy for p185HER2 overexpressing tumors.

Carter P, Rodrigues M L, Lewis G D, Figari I, Shalaby M R

Department of Protein Engineering, Genentech Inc., South San Francisco, CA 94080.

Adv Exp Med Biol. 1994;353:83-94. doi: 10.1007/978-1-4615-2443-4_9.

Abstract

摘要

Adv Exp Med Biol. 1994;353:83-94. doi: 10.1007/978-1-4615-2443-4_9.

Curr Top Microbiol Immunol. 1996;213 ( Pt 3):113-28. doi: 10.1007/978-3-642-80071-9_8.

Cancer Immunol Immunother. 2004 Jun;53(6):497-509. doi: 10.1007/s00262-003-0465-9. Epub 2003 Nov 25.

Clin Immunol Immunopathol. 1995 Feb;74(2):185-92. doi: 10.1006/clin.1995.1027.

Nat Rev Cancer. 2001 Nov;1(2):118-29. doi: 10.1038/35101072.

Science. 1994 May 6;264(5160):833-5. doi: 10.1126/science.8171337.

Endocr Relat Cancer. 2001 Jun;8(2):83-96. doi: 10.1677/erc.0.0080083.

Int J Cancer. 1995 Jul 28;62(3):319-24. doi: 10.1002/ijc.2910620315.

Cancer Treat Res. 1992;61:193-211. doi: 10.1007/978-1-4615-3500-3_10.

Curr Pharm Biotechnol. 2002 Sep;3(3):237-56. doi: 10.2174/1389201023378256.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。